Cargando…
A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient Tumors
DNA polymerase theta (POLθ) is synthetic lethal with Homologous Recombination (HR) deficiency and thus a candidate target for HR-deficient cancers. Through high-throughput small molecule screens we identified the antibiotic Novobiocin (NVB) as a specific POLθ inhibitor that selectively kills HR-defi...
Autores principales: | Zhou, Jia, Gelot, Camille, Pantelidou, Constantia, Li, Adam, Yücel, Hatice, Davis, Rachel E., Farkkila, Anniina, Kochupurakkal, Bose, Syed, Aleem, Shapiro, Geoffrey I., Tainer, John A., Blagg, Brian S. J., Ceccaldi, Raphael, D’Andrea, Alan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224818/ https://www.ncbi.nlm.nih.gov/pubmed/34179826 http://dx.doi.org/10.1038/s43018-021-00203-x |
Ejemplares similares
-
Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer
por: Patterson-Fortin, Jeffrey, et al.
Publicado: (2023) -
STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer
por: Pantelidou, Constantia, et al.
Publicado: (2022) -
Mutational signatures of non‐homologous and polymerase theta‐mediated end‐joining in embryonic stem cells
por: Schimmel, Joost, et al.
Publicado: (2017) -
The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11
por: Pantelidou, Constantia, et al.
Publicado: (2016) -
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2021)